Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2000 of 2026 entries
View as:

A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01232569 Org: User:
Start: 03/31/11 End: 11/30/13 Due: 11/30/14

A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01326000 Org: User:
Start: 04/30/11 End: 12/31/13 Due: 12/31/14

A Study of Mircera in Hemoglobin Control of Patients Transitioning to Dialysis.

Phase: N/A Priority: Normal
NCT ID: NCT00454246 Org: User:
Start: 04/30/07 End: 02/29/08 Due: 02/28/09

A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)

Phase: N/A Priority: Normal
NCT ID: NCT00891020 Org: User:
Start: 05/31/09 End: 03/31/11 Due: 03/31/12

An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01543503 Org: User:
Start: 02/29/12 End: 02/28/15 Due: 02/28/16

An Observational Study of CellCept (Mycophenolate Mofetil) in Renal Allograft Recipients

Phase: N/A Priority: Normal
NCT ID: NCT01707550 Org: User:
Start: 12/31/09 End: 01/31/11 Due: 01/31/12

A Study of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Advanced and/or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02748213 Org: User:
Start: 02/28/02 End: 01/31/08 Due: 01/31/09

A Study of Once Monthly Intravenous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.

Phase: N/A Priority: Normal
NCT ID: NCT00737464 Org: User:
Start: 08/26/08 End: 09/12/09 Due: 09/12/10

A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01609010 Org: User:
Start: 10/31/02 End: 07/31/11 Due: 07/31/12

A Study of Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04028050 Org: User:
Start: 08/12/19 End: 07/13/23 Due: 07/13/24

A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02563054 Org: User:
Start: 04/30/03 End: 08/31/10 Due: 08/31/11

A Study of RO6807952 in Patients With Diabetes Mellitus Type 2

Phase: N/A Priority: Normal
NCT ID: NCT01358929 Org: User:
Start: 04/30/11 End: 09/30/11 Due: 09/30/12

Study of Low-Dose Radiotherapy (LDRT) Concurrent Cisplatin/Carboplatin Plus Etoposide With Atezolizumab for Patients With Extensive-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04622228 Org: User:
Start: 12/16/20 End: 06/30/24 Due: 06/30/25

A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01669889 Org: User:
Start: 01/31/13 End: 12/31/13 Due: 12/31/14

BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 Infection

Phase: N/A Priority: Normal
NCT ID: NCT00337701 Org: User:
Start: 06/30/06 End: 01/31/07 Due: 01/31/08

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01457677 Org: User:
Start: 12/31/11 End: 06/30/14 Due: 06/30/15

A Single Center Study to Evaluate the Penetration of RO7033877 Into the Lung in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02165293 Org: User:
Start: 06/30/14 End: 09/30/14 Due: 09/30/15

Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea

Phase: N/A Priority: Normal
NCT ID: NCT02538562 Org: User:
Start: 10/11/11 End: 04/19/13 Due: 04/19/14

A Study of RO6926496 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02281786 Org: User:
Start: 01/31/15 End: 10/31/15 Due: 10/31/16

A Study of Safety, Pharmacokinetics (Including Food Effect) And Pharmacodynamics of RO5545965 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01711801 Org: User:
Start: 10/31/12 End: 03/31/13 Due: 03/31/14

A Study of Vismodegib With Surgery in Participants With Previously Untreated Basal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01898598 Org: User:
Start: 01/23/14 End: 01/26/16 Due: 01/26/17

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B.

Phase: N/A Priority: Normal
NCT ID: NCT00460850 Org: User:
Start: 09/30/07 End: 06/30/08 Due: 06/30/09

A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRIGGER)

Phase: N/A Priority: Normal
NCT ID: NCT01378962 Org: User:
Start: 03/31/11 End: 01/31/17 Due: 01/31/18

A Retrospective Chart Review on the Use of Biologics in Monotherapy for the Treatment of Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01640548 Org: User:
Start: 09/30/12 End: 06/30/13 Due: 06/30/14

OPERA Study: A Study of Two Dosing Regimens of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.

Phase: N/A Priority: Normal
NCT ID: NCT02005562 Org: User:
Start: 05/31/06 End: 03/31/09 Due: 03/31/10